Navigation Links
BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
Date:6/16/2009

QUINCY, Mass., June 16 /PRNewswire/ -- BioEnergy International, LLC (BioEnergy), a privately-held, biotech developer and manufacturer of next-generation, renewable biochemicals and biofuels, announces the formation of Myriant Technologies LLC (Myriant) to incorporate all of its biobased chemicals business and intellectual property. BioEnergy will continue its pursuit of biofuels opportunities, including its 110 million gallon per day ethanol plant in Clearfield, Pennsylvania, currently slated for operation in January. The newly-constituted entities will operate as completely separate companies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080211/NEM085LOGO )

The move was made pursuant to the company's continuing emergence in the field of biobased chemicals. "It has become clear over time that we've had two distinct companies operating under the same roof, with different technical requirements and serving different markets and customers," said Stephen J. Gatto, Chairman and Chief Executive Officer. "The new alignment will facilitate a clearer understanding and market valuation of each business for both customers and investors alike."

Myriant will encompass the same world-renowned team of molecular biologists, engineers and chemists that successfully developed BioEnergy's D(-) lactic acid, which started production at commercial scale in June 2008 for use in Polylactic Acid (PLA). D(-) lactic acid solves PLA's thermal stability problem, unlocking the vast potential of PLA by expanding its applications to engineering and high performance plastics. "Our unique combination of extraordinary research and development achievement coupled with commercial execution success sets Myriant apart in this field of huge promise," added Mr. Gatto. "With the ongoing rapid commercialization of our biobased Succinic Acid, Myriant will continue to turn the potential for biobased chemicals as an alternative to petroleum into reality."

Headquartered in Quincy, Massachusetts, Myriant also has a fully integrated, state-of-the-art, 18,000 square foot laboratory located in nearby Woburn.

Contact: Samuel G. McConnell, Sr. VP, Corporate Development, (617) 657-5200


'/>"/>
SOURCE BioEnergy International, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Midwest Research Institute Expands in Kansas to Support Regional Economic Development in Animal Health, Biosecurity, and Bioenergy Sectors
2. Universal Bioenergy, Inc. Expressly Disclaims Any Responsibility for the Content, Accuracy of Information, and Quality of Information Regarding Universal Published by Any Third-Party and Being Disseminated on the Internet
3. Atlantica Bioenergy Task Force hosts industry and government leaders
4. Bioenergy D-Ribose Achieves Highest Safety Standard
5. Media Advisory - Atlantica BioEnergy Task Force Leaders Roundtable
6. Universal Bioenergy, Inc. Seeks Algae Feedstock Companies for Acquisition, Alliance, and Joint Venture Opportunities for Biodiesel Production
7. BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board
8. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
9. Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock
10. Raj Khankari Named Bioenergy, Inc., CEO
11. Atlantica BioEnergy Task Force Unveiled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Kineta, Inc., a biotechnology company focused ... immuno-oncology, today announced the discovery and characterization of ... activate interferon response factor 3 (IRF3) via RIG-I ... regression in a murine colon carcinoma mouse model.  ... tumor regression to initial drug treatment were resistant ...
(Date:3/23/2017)... -- According to a report by Transparency Market Research ... to the presence of a large pool of participants; however, only ... and Sigma-Aldrich, compete with each other in this market. With Proliant ... 76% of this market in 2016.  ... As of now, a large number of vendors ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
(Date:3/22/2017)... March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), ... Center (RGC), U.K. Biobank and GSK to generate genetic sequence ... resource. The initiative will enable researchers to gain valuable insights ... a wide range of serious and life threatening diseases. ... Genetic evidence ...
Breaking Biology Technology:
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 ... Family of Companies (Avamere Health Services, Infinity Rehab, Signature ... research study that will apply the power of IBM ... living and health centers. By analyzing data streaming from ... insights into physical and environmental conditions, and obtain deeper ...
(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
(Date:2/8/2017)... 2017 About Voice Recognition Biometrics Voice recognition ... against a stored voiceprint template. Acoustic features of ... tone are compared to distinguish between individual voices. ... most PCs already have a microphone and can ... biometrics are most likely to be deployed in ...
Breaking Biology News(10 mins):